First Capital Advisors Group, Llc. Uni Qure N.V. Call Options Transaction History
First Capital Advisors Group, Llc.
- $188 Million
- Q2 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding QURE
# of Institutions
178Shares Held
50.7MCall Options Held
2.13MPut Options Held
480K-
Vestal Point Capital, LP New York, NY4.79MShares$74.3 Million3.63% of portfolio
-
Rtw Investments, LP New York, NY4.27MShares$66.1 Million0.74% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.99MShares$61.8 Million3.32% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.76MShares$42.7 Million1.32% of portfolio
-
Abrdn PLC2.22MShares$34.3 Million0.05% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $724M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...